company background image
STIM logo

Neuronetics NasdaqGM:STIM Stock Report

Last Price

US$1.93

Market Cap

US$57.7m

7D

2.9%

1Y

-6.6%

Updated

21 Jul, 2024

Data

Company Financials +

Neuronetics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Neuronetics
Historical stock prices
Current Share PriceUS$1.93
52 Week HighUS$5.07
52 Week LowUS$1.03
Beta2.32
11 Month Change5.19%
3 Month Change-48.53%
1 Year Change-6.55%
33 Year Change-85.74%
5 Year Change-83.22%
Change since IPO-93.07%

Recent News & Updates

Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

May 24
Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 09
The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Neuronetics: Reality Set In

May 09

Recent updates

Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

May 24
Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 09
The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Neuronetics: Reality Set In

May 09

Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 36% Lower

May 08
Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 36% Lower

Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?

May 01
Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?

Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely

Mar 17
Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely

Neuronetics: Modest Improvements Are Not Enough

Jan 30

Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward

Dec 19
Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story

Jun 21
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story

Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?

May 10
Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?

Neuronetics: Growth To Capture, But Fairly Priced

Sep 06

Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?

Sep 06
Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?

Neuronetics gets FDA nod for its D-Tect accessory product for use to treat depression

Aug 29

Neuronetics GAAP EPS of -$0.39 beats by $0.02, revenue of $16.3M beats by $0.84M , revises FY guidance

Aug 02

Neuronetics stock soars 30% as FDA clears NeuroStar system for anxious depression

Jul 19

Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Jun 08
Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Is Neuronetics (NASDAQ:STIM) Weighed On By Its Debt Load?

Jan 19
Is Neuronetics (NASDAQ:STIM) Weighed On By Its Debt Load?

Shareholder Returns

STIMUS Medical EquipmentUS Market
7D2.9%-0.02%-1.9%
1Y-6.6%-2.6%19.4%

Return vs Industry: STIM underperformed the US Medical Equipment industry which returned -2.6% over the past year.

Return vs Market: STIM underperformed the US Market which returned 19.4% over the past year.

Price Volatility

Is STIM's price volatile compared to industry and market?
STIM volatility
STIM Average Weekly Movement12.0%
Medical Equipment Industry Average Movement7.8%
Market Average Movement5.9%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

Stable Share Price: STIM's share price has been volatile over the past 3 months.

Volatility Over Time: STIM's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2001202Keith Sullivanneurostar.com

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.

Neuronetics, Inc. Fundamentals Summary

How do Neuronetics's earnings and revenue compare to its market cap?
STIM fundamental statistics
Market capUS$57.75m
Earnings (TTM)-US$27.54m
Revenue (TTM)US$73.23m

0.8x

P/S Ratio

-2.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
STIM income statement (TTM)
RevenueUS$73.23m
Cost of RevenueUS$17.93m
Gross ProfitUS$55.30m
Other ExpensesUS$82.84m
Earnings-US$27.54m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.92
Gross Margin75.52%
Net Profit Margin-37.61%
Debt/Equity Ratio214.9%

How did STIM perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.